This topic contains a solution. Click here to go to the answer

Author Question: A client with bipolar disorder has a lithium drug level of 1.2 mEq/L. Which of the following would ... (Read 70 times)

jilianpiloj

  • Hero Member
  • *****
  • Posts: 521
A client with bipolar disorder has a lithium drug level of 1.2 mEq/L. Which of the following would the nurse expect to assess? Select all that apply.
 
  A) Metallic taste
  B) Ataxia
  C) Diarrhea
  D) Slurred speech
  E) Fasciculations
  F) Muscle weakness

Question 2

The nurse is caring for a client diagnosed as being in the advanced stages of AIDS. A priority nursing assessment for this client is for:
 
  A) Sensory impairment.
  B) Cognitive impairment.
  C) Social behaviors.
  D) Anxiety state.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tranoy

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

C, D, E

Answer to Question 2

B





 

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library